Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.
New research following Spanish adults over 7 years found that higher levels of specific gut-derived fatty acids in the blood—especially butyrate and isobutyrate—were linked to an increased risk of developing type 2 diabetes, offering insights into early risk prediction.
A randomized trial found that while both Mediterranean and low-FODMAP diets improved symptoms in patients with nonconstipated IBS, the low-FODMAP diet led to greater reductions in symptom severity.
A multicenter study of pediatric patients treated with fidaxomicin for C difficile found over half were cured by two weeks, and only one in five had a recurrence within two months.
A 92-hospital trial found that simple prompts in electronic health records helped reduce the use of broad-spectrum antibiotics in low-risk abdominal infection cases—without increasing ICU stays or length of hospitalization.
Study highlights how 'Proteobacteria and bile acids in the gut negatively impact insulin sensitivity,' offering potential therapeutic targets across the microbiome-gut-adipose-liver axis.
Researchers identified segment-specific effects of immune cells on intestinal contractions, providing new angles for managing inflammatory bowel disease.